ArticlemSystems2026
Pandoomain, a scalable pipeline for genomic and protein domain context analysis, reveals widespread PT-TG domain architectural diversity and novel polymorphic toxins.
Article in mSystems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The rapid expansion of bacterial genome databases presents significant opportunities for functional discovery, as a large fraction of genes and protein domains remain uncharacterized. Analyzing genomic context and domain architecture is a powerful approach for functional inference, but existing tools often lack the scalability and integrated workflow required for high-throughput analysis. To address this, we developed Pandoomain, a Snakemake pipeline that automates the acquisition of genomes from the National Center for Biotechnology Information, identifies proteins of interest using hidden Markov models (HMMs), and performs systematic domain annotation and gene neighborhood analysis. We demonstrate the utility of Pandoomain through a comprehensive analysis of the poorly characterized pre-toxin TG (PT-TG) domain across 347,289 bacterial genomes. Our analysis revealed 10,226 PT-TG-containing proteins organized into 312 unique domain architectures, highlighting their association with diverse interbacterial antagonistic systems, including the Type VI secretion, Type VII secretion, and contact-dependent inhibition systems. By leveraging genomic context, we identified a novel variant of the WXG trafficking domain, termed W10XG, and subsequently discovered 24 new families of associated toxin domains. We experimentally validated six of these toxins, confirming that all six are neutralized by their cognate immunity proteins. Pandoomain is an accessible tool that enables systematic, large-scale exploration of protein domains, and our analysis of the PT-TG domain provides a rich resource for future investigations into the mechanisms and evolution of bacterial antagonism.IMPORTANCEThe rapid growth of bacterial genomic data presents a major hurdle for scientists seeking to understand the functions of newly discovered genes and proteins. To address this issue, we created Pandoomain, a powerful, accessible software tool that automates large-scale analysis of genetic information across hundreds of thousands of genomes. Using Pandoomain, we investigated a poorly understood family of proteins involved in bacterial competition, revealing novel protein domain architectural diversity. This led to the discovery of 24 new families of toxins predicted to be used by bacteria to attack their competitors, and we experimentally confirmed the toxic activity of six of them. Our work provides the scientific community with a robust tool to accelerate functional discovery and offers new insights into the evolution of bacterial conflicts, which may provide insights into the compositional dynamics of microbial communities and support methods to engineer their composition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.